Zachary Leblanc
Pediatric Hematology-Oncology · New Orleans, LANPI 1386888634
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Sobi, Inc accounts for 91.9% of it on its own, with 34 other manufacturers making up the rest. 2025 is the largest year on record at $21,707, more than ten times the $761 reported in 2019.
Across 192 payments — averaging $285.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sobi, Inc$50K
- Genetix Biotherapeutics Inc$864
- Jazz Pharmaceuticals Inc.$503
- Novo Nordisk$432
- Novartis$322
- Sanofi$253
- plus $2K from 29 others
Across 4 payments — averaging $5574.38 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Syndax Pharmaceuticals, Inc.$22K
What the payments were for
- Consulting fees$9,39117%
- Speaking & faculty fees$25,80347%
- Travel & lodging$13,19324%
- Food & beverage$6,28711%
- Education$740%
- Entertainment$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sobi, Inc | 70 | $50,346 |
| Genetix Biotherapeutics Inc | 11 | $864 |
| Jazz Pharmaceuticals Inc. | 5 | $503 |
| Novo Nordisk | 12 | $432 |
| Novartis | 19 | $322 |
| Sanofi | 2 | $253 |
| Servier Pharmaceuticals LLC | 10 | $174 |
| AstraZeneca(2 entities) | 9 | $174 |
| CSL Behring | 6 | $133 |
| Incyte Corporation | 1 | $125 |
| Octapharma USA, Inc. | 3 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $122 |
| Mesoblast, Inc. | 1 | $120 |
| Global Blood Therapeutics, Inc. | 7 | $112 |
| Bioverativ Therapeutics Inc. | 1 | $110 |
| EMD Serono, Inc. | 1 | $100 |
| BTG International Inc. | 2 | $95 |
| Emmaus Medical, Inc. | 4 | $72 |
| Pfizer | 4 | $69 |
| Y-mabs Therapeutics, Inc. | 2 | $62 |
| USWM, LLC | 3 | $56 |
| Eurofins Viracor, LLC | 2 | $52 |
| HEMA Biologics, LLC | 2 | $50 |
| Seagen Inc. | 2 | $42 |
| Genentech USA, Inc. | 2 | $40 |
| Vertex | 1 | $30 |
| Fennec Pharmaceuticals, Inc. | 1 | $28 |
| Apellis Pharmaceuticals, Inc. | 1 | $25 |
| Medunik USA Inc. | 1 | $25 |
| Chiesi USA, Inc. | 1 | $19 |
| RARE Disease Therapeutics, Inc. | 1 | $18 |
| Adaptive Biotechnologies Corporation | 1 | $18 |
| Bayer | 1 | $17 |
| Shire North American Group Inc | 1 | $17 |
| Silvergate Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$54,763 in reported general payments places this provider in the 85th percentile of 26 pediatric hematology-oncology providers in Louisiana.
See all pediatric hematology-oncology providers in Louisiana →
Other pediatric hematology-oncology in New Orleans
- Tammuella Chrisentery-SingletonNew Orleans$1.4M
- Maria Velez-YanguasNew Orleans$105K
- Dana LeblancNew Orleans$25K
- Renee GardnerNew Orleans$25K
- Pinki PrasadNew Orleans$20K
- Robert VasquezNew Orleans$6K
- Lolie YuNew Orleans$3K
- Craig LottermanNew Orleans$3K
- Cori MorrisonNew Orleans$1K
- Justin FargeNew Orleans$797
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.